When NF‐κB is normally expressed, it plays a protective role in neurons, but excessive activation of NF‐κB can result in the release of a large amount of inflammatory factors in glial cells, and subsequent acceleration of the development of AD. Here, NFKB1 is linked to Alzheimer disease.